Therapeutic Asset Ratings

603 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Selinexor Malignant Peripheral Nerve Sheath Tumor	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Selinexor MPNST	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Selinexor Nephroblastoma	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Selinexor Rhabdoid Tumor	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Selinexor Neoplasm	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Selinexor Wilms Tumor	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Selinexor XPO1 Gene Mutation	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Siltuximab AL Amyloidosis	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
TACROLIMUS Beta Thalassemia	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Trastuzumab Deruxtecan Brain Cancer	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Trastuzumab Emtansine Solid Tumor Cancers	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Trastuzumab Emtansine Urinary System Neoplasm	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Triamcinalone Toxic Dermatosis	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Vericiguat Heart Failure	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Zoladex Lobular Breast Carcinoma	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
PROPRANOLOL Primary Peritoneal Carcinoma	Memorial Sloan Kettering Cancer Center	P1	CCC (53)
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 1.BETA.) (HUMAN CLONE ACZ885 HEAVY CHAIN V REGION) Non-Small Cell Lung Carcinoma	Memorial Sloan Kettering Cancer Center	P3	CCC (52)
Bortezomib Sickle Cell Disease	Memorial Sloan Kettering Cancer Center	P2	CCC (52)
Entinostat Refractory	Memorial Sloan Kettering Cancer Center	P2	CCC (52)
Fam-Trastuzumab Deruxtecan-Nxki HER2 Positive Breast Carcinoma	Memorial Sloan Kettering Cancer Center	P2	CCC (52)
Hpc, Cord Blood Hodgkins Lymphoma	Memorial Sloan Kettering Cancer Center	P2	CCC (52)
Inno-206 Sickle Cell Disease	Memorial Sloan Kettering Cancer Center	P2	CCC (52)
TRASTUZUMAB Lymphoma	Memorial Sloan Kettering Cancer Center	P2	CCC (52)
Calcium folinate pentahydrate Diffuse Pleural Mesothelioma	Memorial Sloan Kettering Cancer Center	P1/2	CCC (52)
FULVESTRANT MEK1 Gene Mutation	Memorial Sloan Kettering Cancer Center	P1/2	CCC (52)

Showing 251 to 275 of 603 assets

PreviousPage 11 of 25Next